BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20135302)

  • 1. Uterus conserving prolapse surgery--what is the chance of missing a malignancy?
    Renganathan A; Edwards R; Duckett JR
    Int Urogynecol J; 2010 Jul; 21(7):819-21. PubMed ID: 20135302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.
    Hemming C; Constable L; Goulao B; Kilonzo M; Boyers D; Elders A; Cooper K; Smith A; Freeman R; Breeman S; McDonald A; Hagen S; Montgomery I; Norrie J; Glazener C
    Health Technol Assess; 2020 Mar; 24(13):1-220. PubMed ID: 32138809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult Uterine Malignancy at the Time of Surgery for Pelvic Organ Prolapse: A Systematic Review and Meta-analysis.
    Davenport E; James L; Parks T; Howard DL
    Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):e282-e289. PubMed ID: 32604198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dutch women's attitudes towards hysterectomy and uterus preservation in surgical treatment of pelvic organ prolapse.
    van IJsselmuiden MN; Detollenaere RJ; Gerritse MBE; Kluivers KB; Bongers MY; van Eijndhoven HWF
    Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():79-83. PubMed ID: 29175132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Occult Uterine Pathology in Women Undergoing Hysterectomy With Pelvic Organ Prolapse Repair.
    Ackenbom MF; Giugale LE; Wang Y; Shepherd JP
    Female Pelvic Med Reconstr Surg; 2016; 22(5):332-5. PubMed ID: 27171317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence and risk factors of occult malignancy in patients receiving vaginal hysterectomy for pelvic organ prolapse.
    Ryu SM; Cho JS; Kong MK; Bai SW
    Int Urogynecol J; 2023 Nov; 34(11):2719-2724. PubMed ID: 37401960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications.
    Mahnert N; Morgan D; Campbell D; Johnston C; As-Sanie S
    Obstet Gynecol; 2015 Feb; 125(2):397-405. PubMed ID: 25569001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignancy in women who underwent hysterectomy for uterine prolapse.
    Wan OY; Cheung RY; Chan SS; Chung TK
    Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):190-6. PubMed ID: 23316927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine preservation for advanced pelvic organ prolapse repair: Anatomical results and patient satisfaction.
    Fink K; Shachar IB; Braun NM
    Int Braz J Urol; 2016; 42(4):773-8. PubMed ID: 27564289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterus preserving vaginal surgery versus vaginal hysterectomy for correction of female pelvic organ prolapse.
    Iliev VN; Andonova IT
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):243-7. PubMed ID: 24802202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomic outcomes after pelvic-organ-prolapse surgery: comparing uterine preservation with hysterectomy.
    Marschalek J; Trofaier ML; Yerlikaya G; Hanzal E; Koelbl H; Ott J; Umek W
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():33-6. PubMed ID: 25461349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hysterectomy for pelvic organ prolapse: indications and techniques.
    Jeppson PC; Sung VW
    Clin Obstet Gynecol; 2014 Mar; 57(1):72-82. PubMed ID: 24145362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massive prolapsed submucous fibroid treated with laparoscopic surgery: A case report.
    Yabumoto K; Ito F; Matsushima H; Mori T; Kusuki I; Kitawaki J
    J Obstet Gynaecol Res; 2019 Apr; 45(4):942-946. PubMed ID: 30681230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of concurrent vaginal hysterectomy in the outcomes of mesh-based vaginal pelvic organ prolapse surgery.
    Forde JC; Chughtai B; Anger JT; Mao J; Sedrakyan A
    Int Urogynecol J; 2017 Aug; 28(8):1183-1195. PubMed ID: 28091710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected Significant Uterine Pathological Findings at Vaginal Hysterectomy Despite Unremarkable Preoperative Workup.
    Mizrachi Y; Tannus S; Bar J; Sagiv R; Levy T; Condrea A; Ginath S
    Isr Med Assoc J; 2017 Oct; 19(10):631-634. PubMed ID: 29103241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic Uterosacral Ligament Hysteropexy vs Total Vaginal Hysterectomy with Uterosacral Ligament Suspension for Anterior and Apical Prolapse: Surgical Outcome and Patient Satisfaction.
    Haj-Yahya R; Chill HH; Levin G; Reuveni-Salzman A; Shveiky D
    J Minim Invasive Gynecol; 2020 Jan; 27(1):88-93. PubMed ID: 30802607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacrospinous hysteropexy: review and meta-analysis of outcomes.
    Kapoor S; Sivanesan K; Robertson JA; Veerasingham M; Kapoor V
    Int Urogynecol J; 2017 Sep; 28(9):1285-1294. PubMed ID: 28258346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Oophorectomy at the Time of Vaginal Hysterectomy in Patients with Pelvic Organ Prolapse.
    Lua LL; Kosiorek HE; Wasson MN
    J Minim Invasive Gynecol; 2019; 26(6):1063-1069. PubMed ID: 30343033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of histological abnormalities in hysterectomy specimens performed for prolapse. A systematic review and meta-analysis.
    Nicholson RC; Khunda A; Ballard P; Rees J; McCormick C
    Int Urogynecol J; 2021 Dec; 32(12):3131-3141. PubMed ID: 34115164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse].
    Han JS; Zhang K; Zhu FL; Yao Y; Liang HM; Zhou LF; Guo HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):101-4. PubMed ID: 21426766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.